Experts from Yale University have uncovered a new, concerning condition linked to the COVID-19 vaccines. Dubbed “Post-Vaccination Syndrome” (PVS), it not only comes with a host of uncomfortable ...
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the ...
BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) earlier this week outlined progress in its clinical program targeting long COVID, highlighting both the scale of the unmet need and the potential for a ...
Headlines on long COVID have become much more rare than during the first few years of the COVID-19 pandemic. But that doesn’t ...
Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a new study published in The Lancet Infectious Diseases on April 3. “This is ...
In an interview with The American Journal of Managed Care ® (AJMC ®) at the American Thoracic Society International ...
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results